table of content
1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-VEGF Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Drug Overall Market Size
2.1 Global Anti-VEGF Drug Market Size: 2023 VS 2030
2.2 Global Anti-VEGF Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anti-VEGF Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Anti-VEGF Drug Players in Global Market
3.2 Top Global Anti-VEGF Drug Companies Ranked by Revenue
3.3 Global Anti-VEGF Drug Revenue by Companies
3.4 Global Anti-VEGF Drug Sales by Companies
3.5 Global Anti-VEGF Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anti-VEGF Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anti-VEGF Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-VEGF Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-VEGF Drug Market Size Markets, 2023 & 2030
4.1.2 Avastin
4.1.3 Lucentis
4.1.4 Eylea
4.2 By Type - Global Anti-VEGF Drug Revenue & Forecasts
4.2.1 By Type - Global Anti-VEGF Drug Revenue, 2019-2024
4.2.2 By Type - Global Anti-VEGF Drug Revenue, 2025-2030
4.2.3 By Type - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Anti-VEGF Drug Sales & Forecasts
4.3.1 By Type - Global Anti-VEGF Drug Sales, 2019-2024
4.3.2 By Type - Global Anti-VEGF Drug Sales, 2025-2030
4.3.3 By Type - Global Anti-VEGF Drug Sales Market Share, 2019-2030
4.4 By Type - Global Anti-VEGF Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-VEGF Drug Market Size, 2023 & 2030
5.1.2 Age-related Macular Degeneration
5.1.3 Macular Edema Following Retinal Vein Occlusion
5.1.4 Diabetic Macular Edema
5.1.5 Diabetic Retinopathy
5.2 By Application - Global Anti-VEGF Drug Revenue & Forecasts
5.2.1 By Application - Global Anti-VEGF Drug Revenue, 2019-2024
5.2.2 By Application - Global Anti-VEGF Drug Revenue, 2025-2030
5.2.3 By Application - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Anti-VEGF Drug Sales & Forecasts
5.3.1 By Application - Global Anti-VEGF Drug Sales, 2019-2024
5.3.2 By Application - Global Anti-VEGF Drug Sales, 2025-2030
5.3.3 By Application - Global Anti-VEGF Drug Sales Market Share, 2019-2030
5.4 By Application - Global Anti-VEGF Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-VEGF Drug Market Size, 2023 & 2030
6.2 By Region - Global Anti-VEGF Drug Revenue & Forecasts
6.2.1 By Region - Global Anti-VEGF Drug Revenue, 2019-2024
6.2.2 By Region - Global Anti-VEGF Drug Revenue, 2025-2030
6.2.3 By Region - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Anti-VEGF Drug Sales & Forecasts
6.3.1 By Region - Global Anti-VEGF Drug Sales, 2019-2024
6.3.2 By Region - Global Anti-VEGF Drug Sales, 2025-2030
6.3.3 By Region - Global Anti-VEGF Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anti-VEGF Drug Revenue, 2019-2030
6.4.2 By Country - North America Anti-VEGF Drug Sales, 2019-2030
6.4.3 US Anti-VEGF Drug Market Size, 2019-2030
6.4.4 Canada Anti-VEGF Drug Market Size, 2019-2030
6.4.5 Mexico Anti-VEGF Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anti-VEGF Drug Revenue, 2019-2030
6.5.2 By Country - Europe Anti-VEGF Drug Sales, 2019-2030
6.5.3 Germany Anti-VEGF Drug Market Size, 2019-2030
6.5.4 France Anti-VEGF Drug Market Size, 2019-2030
6.5.5 U.K. Anti-VEGF Drug Market Size, 2019-2030
6.5.6 Italy Anti-VEGF Drug Market Size, 2019-2030
6.5.7 Russia Anti-VEGF Drug Market Size, 2019-2030
6.5.8 Nordic Countries Anti-VEGF Drug Market Size, 2019-2030
6.5.9 Benelux Anti-VEGF Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anti-VEGF Drug Revenue, 2019-2030
6.6.2 By Region - Asia Anti-VEGF Drug Sales, 2019-2030
6.6.3 China Anti-VEGF Drug Market Size, 2019-2030
6.6.4 Japan Anti-VEGF Drug Market Size, 2019-2030
6.6.5 South Korea Anti-VEGF Drug Market Size, 2019-2030
6.6.6 Southeast Asia Anti-VEGF Drug Market Size, 2019-2030
6.6.7 India Anti-VEGF Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anti-VEGF Drug Revenue, 2019-2030
6.7.2 By Country - South America Anti-VEGF Drug Sales, 2019-2030
6.7.3 Brazil Anti-VEGF Drug Market Size, 2019-2030
6.7.4 Argentina Anti-VEGF Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-VEGF Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anti-VEGF Drug Sales, 2019-2030
6.8.3 Turkey Anti-VEGF Drug Market Size, 2019-2030
6.8.4 Israel Anti-VEGF Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Anti-VEGF Drug Market Size, 2019-2030
6.8.6 UAE Anti-VEGF Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Company Summary
7.1.2 F. Hoffmann-La Roche Ltd Business Overview
7.1.3 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Major Product Offerings
7.1.4 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.1.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.2 Amgen Inc
7.2.1 Amgen Inc Company Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Anti-VEGF Drug Major Product Offerings
7.2.4 Amgen Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Inc Key News & Latest Developments
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Company Summary
7.3.2 Pfizer, Inc Business Overview
7.3.3 Pfizer, Inc Anti-VEGF Drug Major Product Offerings
7.3.4 Pfizer, Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer, Inc Key News & Latest Developments
7.4 Xbrane Biopharma AB
7.4.1 Xbrane Biopharma AB Company Summary
7.4.2 Xbrane Biopharma AB Business Overview
7.4.3 Xbrane Biopharma AB Anti-VEGF Drug Major Product Offerings
7.4.4 Xbrane Biopharma AB Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.4.5 Xbrane Biopharma AB Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Anti-VEGF Drug Major Product Offerings
7.5.4 Allergan Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.5.5 Allergan Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Anti-VEGF Drug Major Product Offerings
7.6.4 Bayer AG Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Regeneron Pharmaceuticals Inc.
7.7.1 Regeneron Pharmaceuticals Inc. Company Summary
7.7.2 Regeneron Pharmaceuticals Inc. Business Overview
7.7.3 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.7.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.8 Viatris Inc
7.8.1 Viatris Inc Company Summary
7.8.2 Viatris Inc Business Overview
7.8.3 Viatris Inc Anti-VEGF Drug Major Product Offerings
7.8.4 Viatris Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.8.5 Viatris Inc Key News & Latest Developments
8 Global Anti-VEGF Drug Production Capacity, Analysis
8.1 Global Anti-VEGF Drug Production Capacity, 2019-2030
8.2 Anti-VEGF Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Drug Supply Chain Analysis
10.1 Anti-VEGF Drug Industry Value Chain
10.2 Anti-VEGF Drug Upstream Market
10.3 Anti-VEGF Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
